Billing and Coding: MolDX: Pharmacogenomics Testing (A57384) - R18 - Effective September 2, 2025

Date Posted: November 13, 2025

This Billing and Coding Article has been revised under contract numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).

Effective Date: September 2, 2025

Summary of Changes:

Under Article Text revised Table 1 to add new row for NAT2 for hydralazine. This revision is due to CPIC guidelines and is effective 9/2/2025.

Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.

Last Updated Nov 13 , 2025